The FDA approved the fourth natural food color additive this year, but how can you avoid the artificial dyes still out there?

Pierre Fabre leads global development of tab-cel, an innovative therapy for EBV+ PTLD, with ongoing trials and potential FDA ...

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

Gardenia (genipin) blue is the fourth natural food color additive the FDA has approved this year, but how is it made?

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

The Food and Drug Administration has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.

FDA requires labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD. FDA. Drug Safety Communication. June 30, 2025.

Yesafili, a biosimilar to Eylea, received Health Canada's approval, marking the first such approval in Canada. Indicated for neovascular AMD, diabetic macular edema, and other ocular conditions, ...

Novel disposable sensor pad and software offers a simple, universal, and cost-effective solution for managing respiratory motion in image-guided radiation therapy MINNEAPOLIS, June 30, 2025 ...